The FDA approved Trogarzo (ibalizumab-uiyk), a new type of antiretroviral medication for adult patients living with HIV who have tried multiple HIV medications in the past (heavily treatment-experienced) and whose HIV infections cannot be successfully treated with other currently available therapies.
FDA has authorized 23andMe to market a consumer test that reports only 3 out of more than 1,000 known mutations in BRCA genes
FDA announces commitment to modernize and streamline our food and nutrition programs to make sure that our investments of new and existing resources achieve their intended public health goals.
FDA warns of fraudulent and unapproved flu products
FDA is alerting not to use drug products produced by Cantrell Drug Company that were distributed nationwide.
Americans rely on the U.S. Food and Drug Administration to ensure that food labels contain updated nutritional information to help them make more informed food choices that lead to better health for themselves and their families. I’ve made nutrition one of my top priorities, and ensuring that consumers have accurate and science-based information concerning the […]
FDA provides update on flu vaccines during this severe flu season
FDA provides update on Clarity-BPA
FDA oversees destruction and recall of kratom products; and reiterates its concerns on risks associated with this opioid
FDA approves drug to reduce the risk of stage III non-small cell lung cancer progressing
FDA provides update on flu vaccines during this severe flu season
FDA expands treatment window for use of clot retrieval devices in certain stroke patient
FDA’s 5 guidance documents provide details for drug development for neurological conditions such as ALS and Alzheimer’s disease
FDA approves Erleada (apalutamide), first treatment for non-metastatic, castration-resistant prostate cancer
FDA authorizes marketing of first blood test to aid in the evaluation of concussion in adults; new quick testing option to help reduce need for CT scans, radiation exposure for patients
FDA permits marketing of clinical decision support software for alerting providers of a potential stroke in patients
Statement from FDA Commissioner Scott Gottlieb, M.D., on Administration’s request for new FDA funding to promote innovation and broaden patient access through competition
FDA announces on groundbreaking approval and interagency approach to bring stable supply of critical medical imaging isotope to the U.S.
FDA and NRC today took important steps to ensure a stable and secure supply of a critical radioactive imaging product used to detect potentially life-threatening diseases